Bayer AG raised its annual profit outlook, buoyed by a better-than-expected performance at its pharmaceutical unit.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论,并结合市场和 OSINT 背景分析。

Bayer AG raised its annual profit outlook, buoyed by a better-than-expected performance at its pharmaceutical unit.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论,并结合市场和 OSINT 背景分析。